Product References
The Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Breast Cancer Are Regulated by N-Linked Glycosylation-Dependent Activation of STAT3 and STAT1.
Cells
Erlichman N,Meshel T,Baram T,Abu Raiya A,Horvitz T,Ben-Yaakov H,Ben-Baruch A
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 56-5983-42) in Flow Cytometry
Sat Sep 23 00:00:00 EDT 2023
NKp44-Derived Peptide Used in Combination Stimulates Antineoplastic Efficacy of Targeted Therapeutic Drugs.
International journal of molecular sciences
Iraqi M,Bolel P,Sarkar R,Bhattacharya B,Abu Ahmad M,Edri A,Roisman LC,Elkabets M,Shalata W,Peled N,Porgador A
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 56-5983-42) in Flow Cytometry
Mon Nov 14 00:00:00 EST 2022
FOXM1 Inhibition Enhances the Therapeutic Outcome of Lung Cancer Immunotherapy by Modulating PD-L1 Expression and Cell Proliferation.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Madhi H,Lee JS,Choi YE,Li Y,Kim MH,Choi Y,Goh SH
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 56-5983-42) in Immunocytochemistry
Sat Oct 01 00:00:00 EDT 2022
GM-CSF, Flt3-L and IL-4 affect viability and function of conventional dendritic cell types 1 and 2.
Frontiers in immunology
Lellahi SM,Azeem W,Hua Y,Gabriel B,Paulsen Rye K,Reikvam H,Kalland KH
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 56-5983-42) in Flow Cytometry
Wed Feb 01 00:00:00 EST 2023
PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells.
Journal for immunotherapy of cancer
Bajor M,Graczyk-Jarzynka A,Marhelava K,Burdzinska A,Muchowicz A,Goral A,Zhylko A,Soroczynska K,Retecki K,Krawczyk M,Klopotowska M,Pilch Z,Paczek L,Malmberg KJ,Wälchli S,Winiarska M,Zagozdzon R
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 56-5983-42) in Flow Cytometry
Sat Jan 01 00:00:00 EST 2022
PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells.
Journal for immunotherapy of cancer
Bajor M,Graczyk-Jarzynka A,Marhelava K,Burdzinska A,Muchowicz A,Goral A,Zhylko A,Soroczynska K,Retecki K,Krawczyk M,Klopotowska M,Pilch Z,Paczek L,Malmberg KJ,Wälchli S,Winiarska M,Zagozdzon R
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 56-5983-42) in Flow Cytometry
Sat Jan 01 00:00:00 EST 2022
Ruxolitinib reverses checkpoint inhibition by reducing programmed cell death ligand-1 (PD-L1) expression and increases anti-tumour effects of T cells in multiple myeloma.
British journal of haematology
Chen H,Li M,Ng N,Yu E,Bujarski S,Yin Z,Wen M,Hekmati T,Field D,Wang J,Nassir I,Yu J,Huang J,Daniely D,Wang CS,Xu N,Spektor TM,Berenson JR
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 56-5983-42) in Flow Cytometry
Mon Feb 01 00:00:00 EST 2021
Different Induction of PD-L1 (CD274) and PD-1 (CD279) Expression in THP-1-Differentiated Types 1 and 2 Macrophages.
Journal of inflammation research
Lai CY,Tseng PC,Chen CL,Satria RD,Wang YT,Lin CF
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 56-5983-42) in Flow Cytometry
Wed Apr 27 00:00:00 EDT 2022
Protecting Stem Cell Derived Pancreatic Beta-Like Cells From Diabetogenic T Cell Recognition.
Frontiers in endocrinology
Castro-Gutierrez R,Alkanani A,Mathews CE,Michels A,Russ HA
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 56-5983-42) in Flow Cytometry
Thu Feb 10 00:00:00 EST 2022
IL-27 Mediates PD-L1 Expression and Release by Human Mesothelioma Cells.
Cancers
Carbotti G,Dozin B,Martini S,Giordano C,Scordamaglia F,Croce M,Filaci G,Ferrini S,Fabbi M
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 56-5983-42) in Flow Cytometry
Mon Aug 09 00:00:00 EDT 2021
Concomitant High Apoptosis Inhibitor of Macrophage (AIM) and Low Prostate-Specific Antigen (PSA) Indicates Activated T Cell-Mediated Anticancer Immunity, Enhance Sensitivity to Pembrolizumab, and Elicit Good Prognosis in Prostate Cancer.
Biomedicines
Bamodu OA,Wang YH,Yeh CT,Ho CH,Chiang YT,Kao WT,Liu CH,Wu CC
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 56-5983-42) in Immunohistochemistry
Wed Sep 15 00:00:00 EDT 2021
NEK2 inhibition triggers anti-pancreatic cancer immunity by targeting PD-L1.
Nature communications
Zhang X,Huang X,Xu J,Li E,Lao M,Tang T,Zhang G,Guo C,Zhang X,Chen W,Yadav DK,Bai X,Liang T
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 56-5983-42) in Immunocytochemistry
Tue Jul 27 00:00:00 EDT 2021
Protocol for high-throughput compound screening using flow cytometry in THP-1 cells.
STAR protocols
Spangenberg SH,Zavareh RB,Lairson LL
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 56-5983-42) in Flow Cytometry
Fri Jun 18 00:00:00 EDT 2021
Microbe-Mediated Activation of Toll-like Receptor 2 Drives PDL1 Expression in HNSCC.
Cancers
Mann JE,Ludwig ML,Kulkarni A,Scheftz EB,Murray IR,Zhai J,Gensterblum-Miller E,Jiang H,Brenner JC
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 56-5983-42) in Western Blot
Fri Sep 24 00:00:00 EDT 2021
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19.
Science immunology
Asano T,Boisson B,Onodi F,Matuozzo D,Moncada-Velez M,Maglorius Renkilaraj MRL,Zhang P,Meertens L,Bolze A,Materna M,Korniotis S,Gervais A,Talouarn E,Bigio B,Seeleuthner Y,Bilguvar K,Zhang Y,Neehus AL,Ogishi M,Pelham SJ,Le Voyer T,Rosain J,Philippot Q,Soler-Palacín P,Colobran R,Martin-Nalda A,Rivière JG,Tandjaoui-Lambiotte Y,Chaïbi K,Shahrooei M,Darazam IA,Olyaei NA,Mansouri D,Hatipoğlu N,Palabiyik F,Ozcelik T,Novelli G,Novelli A,Casari G,Aiuti A,Carrera P,Bondesan S,Barzaghi F,Rovere-Querini P,Tresoldi C,Franco JL,Rojas J,Reyes LF,Bustos IG,Arias AA,Morelle G,Christèle K,Troya J,Planas-Serra L,Schlüter A,Gut M,Pujol A,Allende LM,Rodriguez-Gallego C,Flores C,Cabrera-Marante O,Pleguezuelo DE,de Diego RP,Keles S,Aytekin G,Akcan OM,Bryceson YT,Bergman P,Brodin P,Smole D,Smith CIE,Norlin AC,Campbell TM,Covill LE,Hammarström L,Pan-Hammarström Q,Abolhassani H,Mane S,Marr N,Ata M,Al Ali F,Khan T,Spaan AN,Dalgard CL,Bonfanti P,Biondi A,Tubiana S,Burdet C,Nussbaum R,Kahn-Kirby A,Snow AL,Bustamante J,Puel A,Boisson-Dupuis S,Zhang SY,Béziat V,Lifton RP,Bastard P,Notarangelo LD,Abel L,Su HC,Jouanguy E,Amara A,Soumelis V,Cobat A,Zhang Q,Casanova JL
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 56-5983-42) in Flow Cytometry
Thu Aug 19 00:00:00 EDT 2021
TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9.
Nature
Heinz LX,Lee J,Kapoor U,Kartnig F,Sedlyarov V,Papakostas K,César-Razquin A,Essletzbichler P,Goldmann U,Stefanovic A,Bigenzahn JW,Scorzoni S,Pizzagalli MD,Bensimon A,Müller AC,King FJ,Li J,Girardi E,Mbow ML,Whitehurst CE,Rebsamen M,Superti-Furga G
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 56-5983-42) in Flow Cytometry
Fri May 01 00:00:00 EDT 2020
β-Catenin induces transcriptional expression of PD-L1 to promote glioblastoma immune evasion.
The Journal of experimental medicine
Du L,Lee JH,Jiang H,Wang C,Wang S,Zheng Z,Shao F,Xu D,Xia Y,Li J,Zheng Y,Qian X,Li X,Kim HR,Xing D,Liu P,Lu Z,Lyu J
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 56-5983-42) in Flow Cytometry
Mon Nov 02 00:00:00 EST 2020
Protein kinase D3 regulates the expression of the immunosuppressive protein, PD‑L1, through STAT1/STAT3 signaling.
International journal of oncology
Cui B,Chen J,Luo M,Wang L,Chen H,Kang Y,Wang J,Zhou X,Feng Y,Zhang P
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 56-5983-42) in Flow Cytometry
Wed Apr 01 00:00:00 EDT 2020
Contribution of GATA6 to homeostasis of the human upper pilosebaceous unit and acne pathogenesis.
Nature communications
Oulès B,Philippeos C,Segal J,Tihy M,Vietri Rudan M,Cujba AM,Grange PA,Quist S,Natsuga K,Deschamps L,Dupin N,Donati G,Watt FM
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 56-5983-42) in Flow Cytometry
Tue Oct 20 00:00:00 EDT 2020
Cancer cell-intrinsic expression of MHC II in lung cancer cell lines is actively restricted by MEK/ERK signaling and epigenetic mechanisms.
Journal for immunotherapy of cancer
Neuwelt AJ,Kimball AK,Johnson AM,Arnold BW,Bullock BL,Kaspar RE,Kleczko EK,Kwak JW,Wu MH,Heasley LE,Doebele RC,Li HY,Nemenoff RA,Clambey ET
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 56-5983-42) in Flow Cytometry
Wed Apr 01 00:00:00 EDT 2020
Phospho‑STAT1 expression as a potential biomarker for anti‑PD‑1/anti‑PD‑L1 immunotherapy for breast cancer.
International journal of oncology
Nakayama Y,Mimura K,Tamaki T,Shiraishi K,Kua LF,Koh V,Ohmori M,Kimura A,Inoue S,Okayama H,Suzuki Y,Nakazawa T,Ichikawa D,Kono K
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 56-5983-42) in Flow Cytometry
Sat Jun 01 00:00:00 EDT 2019
Quantitative Interactomics in Primary T Cells Provides a Rationale for Concomitant PD-1 and BTLA Coinhibitor Blockade in Cancer Immunotherapy.
Cell reports
Celis-Gutierrez J,Blattmann P,Zhai Y,Jarmuzynski N,Ruminski K,Grégoire C,Ounoughene Y,Fiore F,Aebersold R,Roncagalli R,Gstaiger M,Malissen B
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 56-5983-42) in Flow Cytometry
Tue Jun 11 00:00:00 EDT 2019
High PD-L1 Expression Predicts for Worse Outcome of Leukemia Patients with Concomitant NPM1 and FLT3 Mutations.
International journal of molecular sciences
Brodská B,Otevřelová P,Šálek C,Fuchs O,Gašová Z,Kuželová K
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 56-5983-42) in Flow Cytometry
Mon Jun 10 00:00:00 EDT 2019
Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids.
Cell
Dijkstra KK,Cattaneo CM,Weeber F,Chalabi M,van de Haar J,Fanchi LF,Slagter M,van der Velden DL,Kaing S,Kelderman S,van Rooij N,van Leerdam ME,Depla A,Smit EF,Hartemink KJ,de Groot R,Wolkers MC,Sachs N,Snaebjornsson P,Monkhorst K,Haanen J,Clevers H,Schumacher TN,Voest EE
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 56-5983-42) in Flow Cytometry
Thu Sep 06 00:00:00 EDT 2018
Specific expression of PD-L1 in RELA-fusion supratentorial ependymoma: Implications for PD-1-targeted therapy.
Pediatric blood & cancer
Witt DA,Donson AM,Amani V,Moreira DC,Sanford B,Hoffman LM,Handler MH,Levy JMM,Jones KL,Nellan A,Foreman NK,Griesinger AM
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 56-5983-42) in Flow Cytometry
Tue May 01 00:00:00 EDT 2018
A versatile T cell-based assay to assess therapeutic antigen-specific PD-1-targeted approaches.
Oncotarget
Versteven M,Van den Bergh JMJ,Broos K,Fujiki F,Campillo-Davo D,De Reu H,Morimoto S,Lecocq Q,Keyaerts M,Berneman Z,Sugiyama H,Van Tendeloo VFI,Breckpot K,Lion E
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 56-5983-42) in Neutralization
Tue Jun 12 00:00:00 EDT 2018
Similarities and differences between helminth parasites and cancer cell lines in shaping human monocytes: Insights into parallel mechanisms of immune evasion.
PLoS neglected tropical diseases
Narasimhan PB,Akabas L,Tariq S,Huda N,Bennuru S,Sabzevari H,Hofmeister R,Nutman TB,Tolouei Semnani R
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 56-5983-42) in Flow Cytometry
Sun Apr 01 00:00:00 EDT 2018
Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects.
Journal of experimental & clinical cancer research : CR
Xu L,Zhang Y,Tian K,Chen X,Zhang R,Mu X,Wu Y,Wang D,Wang S,Liu F,Wang T,Zhang J,Liu S,Zhang Y,Tu C,Liu H
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 56-5983-42) in Flow Cytometry
Mon Oct 29 00:00:00 EDT 2018
Hormonal vitamin D up-regulates tissue-specific PD-L1 and PD-L2 surface glycoprotein expression in humans but not mice.
The Journal of biological chemistry
Dimitrov V,Bouttier M,Boukhaled G,Salehi-Tabar R,Avramescu RG,Memari B,Hasaj B,Lukacs GL,Krawczyk CM,White JH
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 56-5983-42) in Immunocytochemistry
Fri Dec 15 00:00:00 EST 2017
Upregulation of Programmed Death-1 and Its Ligand in Cardiac Injury Models: Interaction with GADD153.
PloS one
Baban B,Liu JY,Qin X,Weintraub NL,Mozaffari MS
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 56-5983-42) in Neutralization
Tue Apr 12 00:00:00 EDT 2016
Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine.
Oncotarget
Wrangle J,Wang W,Koch A,Easwaran H,Mohammad HP,Vendetti F,Vancriekinge W,Demeyer T,Du Z,Parsana P,Rodgers K,Yen RW,Zahnow CA,Taube JM,Brahmer JR,Tykodi SS,Easton K,Carvajal RD,Jones PA,Laird PW,Weisenberger DJ,Tsai S,Juergens RA,Topalian SL,Rudin CM,Brock MV,Pardoll D,Baylin SB
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 56-5983-42) in Flow Cytometry
Fri Nov 01 00:00:00 EDT 2013